IBM To Build Supercomputer For Disease Research - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


IBM To Build Supercomputer For Disease Research

IBM plans to build the world's largest commercial supercomputer for genetic research company NuTec Sciences Inc. The supercomputing cluster of more than a thousand servers will help scientists find the cause of diseases and identify the best way to treat them.

According to James Coffin, IBM's world director of life-science solutions, the system will be the "fifth or sixth" most powerful computer in the world, and the most powerful computer outside of government use. "It would be 18 to 20,000 times faster than a standard PC," he says, performing 7.5 trillion calculations per second. The supercomputing cluster will consist of 1,250 IBM eServer p640 servers running the company's AIX Operating Systems and DB2 Universal Database. It will have 2.5 terabytes of memory, 50 terabytes of disk storage, and a high-bandwidth networking infrastructure.

The system will be used in part to help scientists understand the genetic basis of diseases. "NuTec is working with the National Institutes of Health to look at very complex diseases such as heart disease and diabetes," says Coffin, and will use the supercomputer to search patient data and identify disease-causing gene combinations. Coffin declined to give the cost of the system, identifying it only as in the "tens of millions."

For IBM, construction of the system represents the company's desire to expand its business in this cutting-edge science. "We house 70% of the world's data," Coffin says, "and we're looking to be the lead data-management company in the world in life sciences." Computing-intensive genetic sciences require powerful machines, but also need massive amounts of data storage and the software to perform the necessary analyses, he says. NuTec is using a lot of IBM's middleware tools, and IBM is working with a number of other genetic research companies as well. Says Coffin, "It's a very long-term strategic industry initiative."

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
Comment  | 
Print  | 
More Insights
State of the Cloud
State of the Cloud
Cloud has drastically changed how IT organizations consume and deploy services in the digital age. This research report will delve into public, private and hybrid cloud adoption trends, with a special focus on infrastructure as a service and its role in the enterprise. Find out the challenges organizations are experiencing, and the technologies and strategies they are using to manage and mitigate those challenges today.
Enterprise Guide to Edge Computing
Cathleen Gagne, Managing Editor, InformationWeek,  10/15/2019
Rethinking IT: Tech Investments that Drive Business Growth
Jessica Davis, Senior Editor, Enterprise Apps,  10/3/2019
IT Careers: 12 Job Skills in Demand for 2020
Cynthia Harvey, Freelance Journalist, InformationWeek,  10/1/2019
Register for InformationWeek Newsletters
Current Issue
Getting Started With Emerging Technologies
Looking to help your enterprise IT team ease the stress of putting new/emerging technologies such as AI, machine learning and IoT to work for their organizations? There are a few ways to get off on the right foot. In this report we share some expert advice on how to approach some of these seemingly daunting tech challenges.
White Papers
Twitter Feed
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.
Sponsored Video
Flash Poll